Evidence map›Paper›PMID 32666676›Full record

ArticleJournal of evaluation in clinical practice2021

The use of mechanistic reasoning in assessing coronavirus interventions.

Jeffrey K Aronson, Daniel Auker-Howlett, Virginia Ghiara, Michael P Kelly, Jon Williamson

Open access · hybridAbstract read
In one paragraph

Article in Journal of evaluation in clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness.International journal of environmental research and public health · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. The use of mechanistic reasoning in assessing coronavirus interventions.Journal of evaluation in clinical practice · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Jeffrey K AronsonCentre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Oxford, UK.ORCID 0000-0003-1139-655X
Daniel Auker-HowlettDepartment of Philosophy and Centre for Reasoning, School of European Culture and Languages, University of Kent, Canterbury, UK.ORCID 0000-0002-2477-863X
Virginia GhiaraDepartment of Philosophy and Centre for Reasoning, School of European Culture and Languages, University of Kent, Canterbury, UK.
Michael P KellyPrimary Care Unit, Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, UK.ORCID 0000-0002-2029-5841
Jon WilliamsonDepartment of Philosophy and Centre for Reasoning, School of European Culture and Languages, University of Kent, Canterbury, UK.ORCID 0000-0003-0514-4209
University of Kent · GBNuffield Health · GBUniversity of Cambridge · GB

Funding

Arts and Humanities Research Council AH/M005917/1Arts and Humanities Research Council Consortium for Humanities and Arts South-East England (CHASE) Doctoral Training Partnership AH/L503861/1Leverhulme Trust RPG-2019-059Marie CurieMRC: Medical Research CouncilNIHR: National Institute For Health ResearchWellcomeWellcome Trust
6 · The paper itself

Abstract

rationaleEvidence-based medicine (EBM), the dominant approach to assessing the effectiveness of clinical and public health interventions, focuses on the results of association studies. EBM+ is a development of EBM that systematically considers mechanistic studies alongside association studies. AIMS AND

objectivesTo explore examples of the importance of mechanistic evidence to coronavirus research.

methodsWe have reviewed the mechanistic evidence in four major areas that are relevant to the management of COVID-19. RESULTS AND

conclusions(a) Assessment of combination therapy for MERS highlights the need for systematic assessment of mechanistic evidence. (b) That hypertension is a risk factor for severe disease in the case of SARS-CoV-2 suggests that altering hypertension treatment might alleviate disease, but the mechanisms are complex, and it is essential to consider and evaluate multiple mechanistic hypotheses. (c) Confidence that public health interventions will be effective requires a detailed assessment of social and psychological components of the mechanisms of their action, in addition to mechanisms of disease. (d) In particular, if vaccination programmes are to be effective, they must be carefully tailored to the social context; again, mechanistic evidence is crucial. We conclude that coronavirus research is best situated within the EBM+ evaluation framework.

Indexed as

Clinical ReasoningEvidence-Based MedicineCOVID-19HumansHypertensionPublic HealthRisk Factorscoronavirusevidence-based medicinemechanismsmechanistic reasoning

Identifiers

PMID32666676
PMCPMC7405225
OpenAlexW3043371086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.